Amanta Healthcare Ltd

Amanta Healthcare Ltd has experienced a notable shift in price momentum, transitioning from a mildly bullish to a bullish technical trend. This change is underpinned by a series of positive signals across key technical indicators, including MACD, moving averages, and Bollinger Bands, signalling renewed investor interest in this micro-cap pharmaceutical stock.

Surging past its previous peaks, Amanta Healthcare Ltd touched a fresh 52-week high of Rs 206.65 on 09 Sep 2026, marking a remarkable 121.8% increase from its 52-week low of Rs 93.10. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and consistent price momentum.

Amanta Healthcare Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching an all-time high stock price of Rs.206.65 on 9 September 2026. This achievement marks a notable phase in the company’s market journey, reflecting sustained gains and strong relative performance against broader benchmarks.

Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend. Despite a recent upgrade in price action, the company’s technical indicators present a nuanced picture, reflecting both strength and caution for investors navigating this evolving landscape.

Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid a backdrop of strong stock returns and sector-wide valuation trends. Investors should carefully analyse the implications of the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical averages and peer benchmarks to gauge price attractiveness going forward.

Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

At Rs 194.92, sellers were still queuing — but there were no buyers willing to take the other side. Amanta Healthcare Ltd locked at its lower circuit of 5.0% on 25 Aug 2026, with unfilled sell orders and a frozen price, signalling a day dominated by supply overwhelming demand.

At Rs 205.57, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Amanta Healthcare Ltd locked at its upper circuit of 5.0% on 24 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Amanta Healthcare Ltd, a player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 24 August 2026, with its stock price touching an all-time high of Rs.204.95. This marks a remarkable achievement for the micro-cap company, reflecting a strong upward momentum over recent weeks and months.

Amanta Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating as of early August 2026. This change reflects evolving market perceptions amid a competitive Pharmaceuticals & Biotechnology sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now aligning more closely with peer averages. Investors are weighing these valuation adjustments against Amanta’s robust stock performance and sector fundamentals.

At Rs 195.83, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Amanta Healthcare Ltd locked at its upper circuit of 5.0% on 20 Aug 2026, with buyers queuing and no sellers willing to part with shares.

After a sustained six-day rally delivering a 25% gain, Amanta Healthcare Ltd surged to a fresh 52-week and all-time high of Rs 195.35 on 21 Aug 2026, outpacing its Pharmaceuticals & Biotechnology sector peers and the broader market indices.

Extending its winning streak to six consecutive sessions, Amanta Healthcare Ltd surged to a fresh all-time high of Rs 195.35 on 21 Aug 2026, outperforming its sector and the broader market by a wide margin.

At Rs 186.51, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Amanta Healthcare Ltd locked at its upper circuit of 5% on 19 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 172.33, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Amanta Healthcare Ltd locked at its upper circuit of 5% on 18 Aug 2026, with buyers queuing and no sellers willing to part with shares.